Heart Disease in Older Adults: Special Considerations

Heart disease remains the leading cause of death among adults aged 65 and older in the United States, accounting for a disproportionate share of hospitalizations, functional decline, and mortality in this population. Managing cardiovascular conditions in older adults requires distinct clinical reasoning because aging changes the physiology of the heart, the presentation of symptoms, and the risk-benefit calculus of standard treatments. This page covers the major cardiovascular conditions affecting older adults, how aging alters their mechanisms, common clinical scenarios, and the decision boundaries that guide care in a geriatric context.

Definition and scope

Cardiovascular disease in older adults encompasses a cluster of conditions that affect the heart and its supporting vasculature. The four most clinically significant forms in the geriatric population are:

  1. Coronary artery disease (CAD) — progressive atherosclerotic narrowing of coronary arteries, leading to ischemia or infarction
  2. Heart failure (HF) — impaired cardiac output or elevated filling pressures, subdivided into heart failure with reduced ejection fraction (HFrEF, EF < 40%) and heart failure with preserved ejection fraction (HFpEF, EF ≥ 50%)
  3. Atrial fibrillation (AF) — the most common sustained cardiac arrhythmia in older adults, affecting approximately 9% of adults over age 65 (CDC, National Center for Chronic Disease Prevention and Health Promotion)
  4. Valvular heart disease — particularly aortic stenosis and mitral regurgitation, whose prevalence increases sharply after age 75

The comprehensive geriatric assessment framework used in geriatric medicine explicitly incorporates cardiovascular status as a domain influencing functional capacity, frailty staging, and care planning. The American College of Cardiology (ACC) and American Heart Association (AHA) jointly publish guidelines — including the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure — that address age-specific management recommendations.

HFpEF deserves particular attention in this population because it predominates in older women and is strongly linked to hypertension, obesity, and left ventricular stiffening that are direct products of vascular aging. Unlike HFrEF, HFpEF has fewer evidence-based pharmacological therapies, making non-pharmacological management — sodium restriction, fluid balance, and exercise — especially important.

How it works

Aging imposes structural and functional changes on the cardiovascular system that make older adults physiologically distinct from younger patients with the same diagnoses. Key mechanisms include:

Symptom presentation also shifts with age. Dyspnea on exertion may be attributed to deconditioning rather than heart failure. Angina may be absent — so-called silent ischemia affects an estimated 20–30% of older adults with documented CAD, according to data reviewed by the National Institute on Aging. Fatigue, confusion, or a sudden decline in functional status may be the presenting symptom of an acute cardiac event rather than chest pain.

Common scenarios

Three clinical scenarios account for the majority of geriatric cardiology encounters:

Acute decompensated heart failure (ADHF): Older adults with HF are hospitalized at higher rates than any other age group for this condition. Precipitants commonly include dietary sodium excess, medication nonadherence, uncontrolled hypertension, or intercurrent infection. Post-discharge 30-day readmission rates for heart failure among Medicare beneficiaries have historically exceeded 20% (CMS Hospital Readmissions Reduction Program), a metric that has driven significant regulatory and quality-improvement attention.

Atrial fibrillation with rate or rhythm management: The clinical decision between rate control and rhythm control in older adults involves weighing stroke risk (quantified by the CHA₂DS₂-VASc score), bleeding risk (quantified by HAS-BLED), fall risk, and the cognitive burden of anticoagulation monitoring. The 2020 ACC/AHA/HRS Guideline for the Diagnosis and Treatment of Atrial Fibrillation notes that older age itself scores 1 point (age 65–74) or 2 points (age ≥ 75) on the CHA₂DS₂-VASc scale, reflecting stroke risk escalation.

Post-acute cardiac rehabilitation: Cardiac rehabilitation improves functional capacity and reduces mortality in older adults after myocardial infarction or heart failure hospitalization, yet utilization among adults over 75 remains substantially lower than in younger cohorts. CMS covers cardiac rehabilitation under Medicare Part B for qualifying diagnoses, as specified in the Medicare & Medicaid Services Coverage Policy.

Decision boundaries

Geriatric cardiology requires explicit evaluation of boundaries that do not arise in standard adult cardiology:

  1. Frailty status: The Clinical Frailty Scale (CFS), developed by Rockwood et al. and validated in surgical and medical populations, stratifies operative and procedural risk. A CFS score ≥ 5 signals vulnerability that materially alters risk-benefit calculations for transcatheter aortic valve replacement (TAVR), coronary revascularization, and device implantation.

  2. Polypharmacy risk: Older adults with cardiovascular disease frequently take five or more medications simultaneously. The Beers Criteria, published by the American Geriatrics Society (AGS) and updated in 2023, flags specific cardiac agents — including digoxin at doses > 0.125 mg/day and certain antiarrhythmics — as potentially inappropriate in older adults due to altered pharmacokinetics and narrow therapeutic windows. See polypharmacy and medication review for structured evaluation approaches.

  3. HFrEF vs. HFpEF management divergence: Guideline-directed medical therapy (GDMT) for HFrEF — ACE inhibitors or ARNIs, beta-blockers, MRAs, and SGLT2 inhibitors — carries Level A evidence. For HFpEF, SGLT2 inhibitors (specifically empagliflozin and dapagliflozin) received updated evidence ratings in the 2022 AHA/ACC/HFSA guidelines, but the overall evidence base remains weaker, shifting emphasis to symptom management and comorbidity control.

  4. Goals-of-care alignment: For older adults with advanced heart failure or multimorbidity, advance care planning and palliative care integration are not supplementary — they are components of guideline-consistent cardiac management. The ACC/AHA Heart Failure guidelines explicitly recommend palliative care referral for patients with Stage D heart failure.

  5. Cognitive and functional screening: Cognitive impairment — present in an estimated 25–30% of older adults with heart failure, per research reviewed by the National Heart, Lung, and Blood Institute (NHLBI) — affects medication adherence, symptom recognition, and the capacity for shared decision-making. Cognitive screening tools such as the Montreal Cognitive Assessment (MoCA) and symptom burden instruments should be integrated into cardiac evaluations for adults over 75. A broad overview of geriatric medicine principles is available at the geriatrics home page.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)